Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568282 · ClinicalTrials.gov registry record
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 219
- Enrollment target
NCT00568282: Completed study, sponsored by Stanford University.
NCT00568282 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 219 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568282 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 219 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.
Interventions
- PROCEDURE phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2007-02 |
| Est. Completion | 2021-07-13 |
What the finished NCT00568282 record still lists
NCT00568282 is an observational study that tracks outcomes without assigning an intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which phlebotomy is the first listed.
NCT00568282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00568282 about?
NCT00568282 is a clinical study titled "Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients". The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.
What is the current status of trial NCT00568282?
This trial is currently completed. The enrollment target is 219 participants. The study started on 2007-02. Estimated completion is 2021-07-13.
What interventions are being tested in trial NCT00568282?
The interventions under investigation include: phlebotomy (PROCEDURE).
Who is sponsoring clinical trial NCT00568282?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia